Michael O’Donnell, MD, FACS

Holden Cancer Center, University of Iowa Hospital – Iowa City, IA

Dr. O’Donnell received his M.D. degree from Duke University. He was a resident in urology, clinical and research fellow, instructor, and assistant professor in surgery at Harvard and a biomedical research fellow at the Whitehead Institute and Beth Israel Deaconess Medical Center in Boston. He is currently Director of Urologic Oncology at the University of Iowa. The author of over 50 peer-reviewed manuscripts, 10 book chapters, and multiple reviews and abstracts, Dr. O’Donnell also serves on the editorial board of the Journal of Urology and CURE. He leads several national clinical trials using immune therapy to treat bladder cancer and holds patents in the genetic manipulation of BCG bacteria.